Clinical Trials Logo

Clinical Trial Summary

Visual analog scales (VAS) are one of the most common tools used in questionnaires. VAS are validated for pain and stress for example on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100). Nowadays, most VAS are used on questionnaires on internet. However, the influence of screen sizes on responses to visual analog scales were never studied.


Clinical Trial Description

Visual analog scales (VAS) are one of the most common tools used in questionnaires. VAS are validated for pain and stress for example on a horizontal, non-calibrated line of 100 mm, ranging from very low (0) to very high (100). Nowadays, most VAS are used on questionnaires on internet. However, the influence of screen sizes on responses to visual analog scales were never studied. Primary objective is to study the influence of screen sizes on response responses to visual analog scales. Secondary objectives are to assess: - the variability of responses depending on screen sizes within a week - the influence of perception of work and addiction to work on the variability depending on screen sizes - relationships with biomarkers of stress : salivary DHEAS, heart rate variability and skin conductance An open questionnaire will be created by the Clinical Research Direction. The questionnaire will be opened by the examinator who will fulfill the anonymized identification of participants and the type of screens. In a dedicated room at the LaPSCo, the participants will answer the same VAS on four different sizes/types of screens (24-inch screen, laptop, tablet, smartphone) and on paper. Saliva will be collected after answering questionnaires. Heart rate variability and skin conductance will be measured with the use of a wrist watch during 15 minutes, from the entrance in the room to the completion of questionnaires. The participant will undergo the same examination within a week (15 minutes). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04040608
Study type Observational
Source University Hospital, Clermont-Ferrand
Contact Lise Laclautre
Phone 334.73.754.963
Email promo_interne_drci@chu-clermontferrand.fr
Status Recruiting
Phase
Start date March 2, 2021
Completion date March 2026

See also
  Status Clinical Trial Phase
Completed NCT02922933 - A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult Subjects Phase 1
Completed NCT02949999 - Voclosporin in Healthy Japanese Volunteers Phase 1
Completed NCT02922946 - Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat Phase 1
Recruiting NCT04038775 - Take 2 Pills and Go Volunteer in the Morning N/A
Completed NCT01974037 - Capsaicin on Salty Gustatory Cortices Phase 4
Completed NCT05789745 - A Study to Evaluate Plasma Gelsolin in Healthy Volunteers Phase 1
Completed NCT03453450 - Exploring Volunteers' Experiences in Health TAPESTRY
Terminated NCT01121380 - A Study Intended to Evaluate Safety, Tolerability and Pharmacokinetics (PK) Parameters of BL-1021 Phase 1
Completed NCT05901662 - Older Volunteers' Competence Training N/A
Terminated NCT02889042 - Repeated Voluntary Drug Intoxication (IMVr): Characterization of a New Addictive Behavior by Clinical Phenotyping and Functional Imaging N/A
Recruiting NCT04256330 - Cardiometabolic Health and Inflammatory Resolution
Completed NCT05760963 - Which Approach to Favor for Ultrasound-guided Lumbar Plexus Block (BPLE). Comparative Study.
Completed NCT03289559 - Effects of Testosterone and Fat Utilization N/A
Enrolling by invitation NCT04643444 - Police COVID-19 Serosurvey
Completed NCT02091271 - Screening Protocol to Evaluate Volunteers for NIA Approved Studies
Completed NCT02622867 - Lactobacillus Plantarum 3547 Effects Over Inflammatory and Immunologic Markers Phase 4
Completed NCT02942667 - Magnetic Resonance Imaging of Human Biometrics N/A
Terminated NCT01573988 - Satiety, Meal Frequency and Nutritional Aspects N/A
Recruiting NCT04516538 - Effects of Mode of Contraction on Neuromuscular Fatigue N/A